MONCTON, N.B. -- A New Brunswick medical marijuana producer says it will aggressively defend itself against a class-action lawsuit launched after unapproved pesticides were found in its products.
Moncton-based Organigram Inc. said it was served notice Monday about the suit, filed on behalf of users of medical marijuana that was found to contain low levels of myclobutanil and bifenazate, pesticides not approved for use by licensed growers.
RELATED: Former Tilray Exec. Appointed New CEO of Organigram
The statement of claim alleges Organigram breached its contract with customers to provide a certified organic product free from unauthorized pesticides.
